secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2021-10-28T23:59:59+00:00
Accession:  0001193125-21-311286
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed reports Q1 FY2022 revenue $904M (+20% YoY), diluted EPS $1.39, non-GAAP EPS $1.51
--------------------------------------------------------------------------------

- Revenue $904.0M, up 20% YoY (19% constant currency); all segments grew double-digits.
- Diluted EPS $1.39 (+14% YoY); non-GAAP diluted EPS $1.51 (+19% YoY).
- Income from operations $261.9M (+21%); non-GAAP operating profit $280.7M (+18%).
- Board declared quarterly cash dividend of $0.42/share, payable Dec 16, 2021, record Nov 11.
- CEO cited strong demand but ongoing supply chain constraints limiting electronic components.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312521311286/0001193125-21-311286-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312521311286/d801447d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-311286

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer